Your browser doesn't support javascript.
loading
Reclassification by applying the Framingham equation 30 years to subjects with intermediate cardiovascular risk. MARK study / Reclasificación utilizando la ecuación de Framingham a 30 años a sujetos con riesgo cardiovascular intermedio. Estudio MARK
Gomez-Sanchez, Leticia; Gomez-Marcos, Manuel A; Patino-Alonso, Maria C; Recio-Rodriguez, Jose I; Gomez-Sanchez, Marta; González-Sánchez, Jesús; Alonso-Domínguez, Rosario; Sánchez-Aguadero, Natalia; Maderuelo-Fernandez, Jose A; Ramos, Rafel; Garcia-Ortiz, Luis; Rodriguez-Sanchez, Emiliano.
Afiliação
  • Gomez-Sanchez, Leticia; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Gomez-Marcos, Manuel A; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Patino-Alonso, Maria C; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Recio-Rodriguez, Jose I; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Gomez-Sanchez, Marta; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • González-Sánchez, Jesús; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Alonso-Domínguez, Rosario; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Sánchez-Aguadero, Natalia; University of Salamanca. Department of Nursing and Physical Therapy. Salamanca. Spain
  • Maderuelo-Fernandez, Jose A; Health Service of Castilla y León (SACyL). Salamanca. Spain
  • Ramos, Rafel; Biomedical Research Institute of Girona Dr. Josep Trueta (IDBGI). Primary Care Research Institute Jordi Gol (IDIAP Jordi Gol). Girona Research Unit. Girona. Spain
  • Garcia-Ortiz, Luis; La Alamedilla Health Center. Primary Health Care Research Unit. Institute of Biomedical Research of Salamanca (IBSAL). Salamanca. Spain
  • Rodriguez-Sanchez, Emiliano; University of Salamanca. Department of Medicine. Salamanca. Spain
Med. clín (Ed. impr.) ; 153(9): 351-356, nov. 2019. graf, tab
Artigo em Inglês | IBECS | ID: ibc-186268
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
Background and

objective:

The estimation of cardiovascular risk (CVR) with scores at 30 years old has a special interest in reclassifying in a suitable way <60 year subjects with intermediate CVR. This study analyzes what percentage of patients with intermediate CVR included in the MARK study is reclassified by applying the 30-year Framingham score (FS30). It also analyzes the degree of agreement between the two equations to classify high risk subjects. Patients and

methods:

Cross-sectional study of 966 subjects included in the MARK study. The CVR was calculated with the two versions of the FS30 (based on lipids and body mass index) for "hard" cardiovascular events in subjects with intermediate CVR.

Results:

The 59% and 61% of the subjects with intermediate CVR would be classified as if they had high CVR to undergo a hard event if we used the FS30 in both versions. 70% of men and 35% of women would be classified as high CVR (p<0.01). The agreement percentage, measured with the Kappa index, between the equations FS30L and FS30BMI to classify the high-risk subjects was 67.9% (in men 67.4% and in women 68.7%).

Conclusions:

In subjects with intermediate CVR the FS30 reclassifies more than the half as high RCV, 2 out of 3 men and 1 out of 3 women
RESUMEN
Antecedentes y

objetivo:

La estimación del riesgo cardiovascular (RCV) con ecuaciones a 30 años tienen un interés especial para reclasificar de manera adecuada los sujetos de 60 años con RCV intermedio. Este estudio analiza qué porcentaje de pacientes con RCV intermedio incluido en el estudio MARK se reclasifica aplicando la puntuación de Framingham a 30 años (FS30) y grado de concordancia entre las 2 ecuaciones para clasificar a los sujetos de riesgo alto. Pacientes y

métodos:

Estudio transversal de 966 sujetos incluidos en el estudio MARK. El RCV se calculó con las 2 versiones del FS30 (basado en los lípidos y el índice de masa corporal) para eventos cardiovasculares «duros» en sujetos con RCV intermedio.

Resultados:

El 59 y el 61% de los sujetos con RCV intermedio se clasificarían como si tuvieran un RCV alto para sufrir un evento difícil si utilizáramos el FS30 en ambas versiones. El 70% de los varones y el 35% de las mujeres se clasificarían como RCV alto (p<0,01). El porcentaje de concordancia, medido con el índice Kappa, entre las ecuaciones FS30L y FS30BMI para clasificar a los sujetos de alto riesgo fue del 67,9% (en varones 67,4% y en mujeres 68,7%).

Conclusiones:

En sujetos con RCV intermedio, el FS30 reclasifica más de la mitad como RCV alto, 2 de cada 3 varones y una de cada 3 mujeres
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Atenção Primária à Saúde / Doenças Cardiovasculares / Estudos Longitudinais / Medição de Risco Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Med. clín (Ed. impr.) Ano de publicação: 2019 Tipo de documento: Artigo Instituição/País de afiliação: Biomedical Research Institute of Girona Dr. Josep Trueta (IDBGI)/Spain / Health Service of Castilla y León (SACyL)/Spain / La Alamedilla Health Center/Spain / University of Salamanca/Spain
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Atenção Primária à Saúde / Doenças Cardiovasculares / Estudos Longitudinais / Medição de Risco Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Med. clín (Ed. impr.) Ano de publicação: 2019 Tipo de documento: Artigo Instituição/País de afiliação: Biomedical Research Institute of Girona Dr. Josep Trueta (IDBGI)/Spain / Health Service of Castilla y León (SACyL)/Spain / La Alamedilla Health Center/Spain / University of Salamanca/Spain
...